Mometasone Furoate (Mometasone Furoate Monohydrate)

The drug acts as an agonist of the glucocorticoid receptor. After binding, the receptor complex alters gene transcription, suppressing the production of inflammatory cytokines and chemokines while enhancing anti‑inflammatory proteins. This reduces swelling and immune cell activity in the nasal mucosa, providing symptom relief.

The prescribed dose of Mometasone furoate nasal spray is determined by a qualified healthcare professional based on the patient’s age, severity of symptoms, and clinical response. Patients should follow the prescriber’s instructions and the product label for proper administration.

Safety data for Mometasone furoate in pregnancy and lactation are limited. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks and benefits with their healthcare provider before using the nasal spray.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Mometasone furoate is a high‑potency intranasal corticosteroid with a favorable safety profile when used at recommended doses. Compared with agents such as fluticasone or budesonide, it offers similar efficacy for allergic rhinitis but may have a lower systemic absorption, reducing the risk of systemic side effects.

Store the nasal spray at ambient temperature below 25 °C, in its original container, protected from moisture and direct sunlight. Do not freeze the product. Keep it out of reach of children and discard any product that appears discolored or cloudy.

Mometasone furoate is administered as a nasal spray. The recommended technique is to gently blow the nose, tilt the head slightly forward, insert the nozzle into one nostril, and spray the prescribed number of sprays while breathing in gently. Repeat in the other nostril if directed by the prescriber.

Serious risks, though rare, include nasal septal perforation, secondary infections such as fungal sinusitis, elevated intraocular pressure leading to glaucoma, and systemic corticosteroid effects like adrenal suppression when used at high doses for prolonged periods. Patients should report persistent nosebleeds, vision changes, or signs of infection promptly.

Individuals with known hypersensitivity to mometasone furoate or any component of the formulation should avoid its use. It is also contraindicated in patients with active untreated nasal or sinus infections, recent nasal surgery, or those who have experienced nasal septal perforation with prior corticosteroid sprays.